Avadel Pharmaceuticals (AWK.F) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.29
-0.21
-0.12
-0.03

Details

Expected EPS
-0.07692623065
Actual EPS
-0.0282585
Surprise EPS
0.05
Surprise Percent
+63.27%

Description

Avadel Pharmaceuticals (AWK.F) has reported earnings of -0.0282585 per share for Q4 2024.

0 Comments

Share your thoughts